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To evaluate the role of sGC in physiology and pathogene-
sis, we generated sGCα1-/- mice and sGCβH105F knock
in mice. The latter have a heme-less and hence NO-resist-
ant sGC, and are a model for the situation in oxidative
stress, where the sGC loses its sensitivity to NO.
We observed that some of the phenotypic differences
observed in sGCα1-/- are dependent on the genetic back-
ground while others are not. So, the gender-specific testo-
sterone hypertension was obvious in male sGCα1-/- mice
on a 129Sv background but not on a C57Bl/6 back-
ground, while the changes in relaxation of gastro-intesti-
nal smooth muscle are identical in sGCα1-/- mice on both
genetic backgrounds. Furthermore, while the presence of
the sGCα2 β1 isoform is sufficient to retain NO respon-
siveness in a number of situations, the sGCα1β isoform
seems to have exclusive roles.
sGCβ1H105F mice show a reduced viability, anatomical
abnormalities, growth retardation, and hypertension. The
blood pressure is no longer sensitive to NO donor com-
pounds or L-NAME but the action of the sGC activator
BAY58-2667 was preserved, confirming the thesis that
BAY58-2667 preferentially activates the heme-free form of
sGC, also in vivo.
The cardiovascular collapse in inflammatory shock (sep-
sis, anaphylaxis,...) is considered to depend on the NOS-
2-sGC-cGK axis. However, except for NOS-3 dependent
anaphylactic shock, which was partially inhibited in
sGCα1-/- mice, various other forms of shock (LPS, TNF)
were not attenuated in the absence of sGC, rather in con-
trast. In addition, we observed that in some situations, as
much NOS-2 and NOS-2 derived NO is present as in
lethal septic shock, without having hemodynamic conse-
quences. These results imply that at least part of the pro-
tective properties of NO in shock are sGC dependent.
They however also question the paradigm that the NO-
sGC-cGK axis is the mediator of distributive shock.
Indeed, we obtained evidence that some Reactive Oxygen
Species might be an alternative candidate mediator, and
might influence the NOS or sGC in shock.
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